Cabaletta Bio, Inc. · NASDAQ:CABA
Citadel Advisors LLC's stake in Cabaletta Bio, Inc. fell to 3.40% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Citadel Advisors LLC's stake in Cabaletta Bio, Inc. fell to 3.40%, 3,150,275 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 3.40%
- Shares
- 3,150,275
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Citadel Advisors LLC | 3.10% | 2,905,465 |
| Citadel Advisors Holdings LP | 3.10% | 2,905,465 |
| Citadel GP LLC | 3.10% | 2,905,465 |
| Citadel Securities LLC | 0.30% | 244,810 |
| Citadel Securities Group LP | 0.30% | 244,810 |
| Citadel Securities GP LLC | 0.30% | 244,810 |
| Kenneth Griffin | 3.40% | 3,150,275 |
Source
Related
- Cabaletta Bio, Inc.
- Citadel Advisors LLC
- Cabaletta Bio, Inc. shareholders
- Schedule 13G · Citadel Advisors LLC · Jun 20, 2025
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G · Norges Bank · Aug 12, 2026